The Relationship Between Metformin And Cancer Cells
A new study, published in the
International Journal of Cancer, found that Metformin used to treat diabetes
helps reduce the risk of death from cancer in some women.
what is The Relationship Between Metformin And Cancer Cells?
The relationship between taking
metformin to treat type 2 diabetes and the reduced risk of dying from cancer is
particularly evident in women with type 2 diabetes who have reached menopause.
The researchers involved in the study
targeted approximately 146,000 women in the menopause stage, ranged in age from
50-79 years, and collected information from participants between 1993 and 1998.
The researchers commented that the
risk of these women developing colon, rectal, and endometrial cancer in
addition to non-Hodgkin lymphoma increased to 25-35%, while the risk was added
to their incidence of liver and pancreatic cancer.
The researchers pointed out that the
results showed that women with type 2 diabetes and cancer had a 45% risk of
dying from cancer compared to women with cancer only.
However, the risk of dying from
cancer decreased in women with both diabetes and cancer, who were taking
metformin, to become very close to women with cancer.
Dr. Zhihong Gong, the lead researcher
in the study, said: "Our results, which we reached by studying a large group
of menopausal women, give clear scientific evidence that these women taking
metformin for the treatment of type 2 diabetes also helps them in the Reduced
risk of dying from cancer more than using any other drug for diabetes. "
The researchers confirmed that
diabetes is considered a risk factor for cancer and even death due to cancer,
but the use of metformin helped women manage the disease better than any other
drug.
And the team of researchers recently
commented that they need to do more studies on the topic to confirm their
long-term relationship.
This is a metformin drug special in
the treatment of type 2 diabetes, as it makes the body more sensitive to
insulin and reduces its resistance to it.
0 Comments